ProMedView and RAIsonance have teamed up to bring you cutting edge technology designed to preserve the workforce and reduce medical spend by:

1. Providing early warnings when the status of the respiratory system is impacted by illness, disease, or environmental exposures.

2. Supporting users in Long COVID recovery.

3. Supporting users in quitting smoking or vaping.

4. Supporting users in managing chronic health conditions such as COPD and CHF.

Note: These products are also available for consumers. Ask about our individual and family pricing.

Neuro COVID is a subcategory of post COVID complications affecting the brain and nervous system. Antibody studies show this occurs in about 40% of those experiencing post viral syndrome.

Although we have passed the emergency phase of the pandemic, COVID will present a continued threat to the workforce and the community as new variants become more contagious. Research has shown that at least 12%-30% of people infected with COVID will develop Post COVID Condition, or Long COVID. This condition can affect anyone of any age and any health status, regardless of the severity of the infection. Symptoms like brain fog, headache, fatigue, depression and insomnia are caused by neural inflammation, and research shows that repeat infections increase the risk of organ failure, brain damage, and central nervous system dysfunction. For those that have already experienced PCC, repeat infections can be expected to increase symptoms and cellular damage.

In order to preserve the workforce, we need options for early diagnosis and early intervention. ProMedView has proudly partnered with RAIsonance to help you meet the safety, health, & wellness challenges ahead using Forced Cough Vocalization & Innovation in Respiratory Wellness. Learn more here.